- Home
- PLUR vs RDI Comparison
PLUR vs RDI Comparison
Compare PLUR & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- RDI
- Stock Information
- Founded
- PLUR 2001
- RDI 1937
- Country
- PLUR Israel
- RDI United States
- Employees
- PLUR N/A
- RDI N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- RDI Movies/Entertainment
- Sector
- PLUR Health Care
- RDI Consumer Discretionary
- Exchange
- PLUR Nasdaq
- RDI Nasdaq
- Market Cap
- PLUR 26.7M
- RDI 30.1M
- IPO Year
- PLUR N/A
- RDI N/A
- Fundamental
- Price
- PLUR $6.75
- RDI $1.29
- Analyst Decision
- PLUR
- RDI Hold
- Analyst Count
- PLUR 0
- RDI 1
- Target Price
- PLUR N/A
- RDI $2.40
- AVG Volume (30 Days)
- PLUR 24.8K
- RDI 43.4K
- Earning Date
- PLUR 05-09-2025
- RDI 05-14-2025
- Dividend Yield
- PLUR N/A
- RDI N/A
- EPS Growth
- PLUR N/A
- RDI N/A
- EPS
- PLUR N/A
- RDI N/A
- Revenue
- PLUR $678,000.00
- RDI $210,527,000.00
- Revenue This Year
- PLUR $472.39
- RDI $11.97
- Revenue Next Year
- PLUR $254.29
- RDI $6.40
- P/E Ratio
- PLUR N/A
- RDI N/A
- Revenue Growth
- PLUR 89.92
- RDI N/A
- 52 Week Low
- PLUR $3.33
- RDI $1.17
- 52 Week High
- PLUR $6.60
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- PLUR 80.65
- RDI 49.51
- Support Level
- PLUR $3.36
- RDI $1.18
- Resistance Level
- PLUR $3.92
- RDI $1.28
- Average True Range (ATR)
- PLUR 0.48
- RDI 0.08
- MACD
- PLUR 0.24
- RDI 0.01
- Stochastic Oscillator
- PLUR 90.00
- RDI 67.65
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.